Search Results for: Research
Bone health is about more than just calcium; recent research suggests that other nutrients play equally crucial roles. Understanding the association between these nutrients can offer new strategies for promoting bone health.
Bone health is about more than just calcium; recent research suggests that other nutrients play equally crucial roles. Understanding the association between these nutrients can offer new strategies for promoting bone health.
Recent research has brought a new player into the conversation around bone health density: Folate, or vitamin B9. While Vitamin K2 MK7 is well known for its essential role in maintaining strong bones, particularly in its ability to regulate calcium and support bone mineral density, the benefits of folate are now emerging as another vital nutrient. A study published in The American Journal of Clinical Nutrition suggests that folate health benefits may include a reduced risk of compromised bone health in older women. The research found that those with higher folate levels had a reduced risk of developing osteoporosis compared to those with lower levels. Researchers believe this effect is linked to active folate‘s ability to reduce homocysteine levels, an amino acid associated with bone density loss, and an increased risk of fractures.
Vitamin K2 is well-known for directing calcium to the bones and teeth while stopping it from depositing in arteries and other tissues, which could otherwise increase cardiovascular risk. It works synergistically with vitamin D to promote bone health. However, the new findings suggest adequate Folate intake could enhance Vitamin K2’s bone-protective role. This revelation is particularly significant as it broadens the understanding of bone health, suggesting that a multi-nutrient approach, including Vitamin K2 and Active Folate, could be more effective in protecting bone health.
Given the increasing prevalence of osteoporosis, especially among aging populations, this research underscores the importance of a balanced diet rich in folate and K2 benefits, alongside other key nutrients like calcium salt and vitamin D, to support bone health density.
The choice of Vitamin K2 and Active Folate is crucial in ensuring the quality and effectiveness of bone health supplements. To guarantee bone health benefits, selecting clinically proven and high-quality forms of these nutrients is essential.
MenaQ7® and Quatrefolic® are leading choices in this regard. They offer the reliable efficacy needed to support bone health through scientifically backed ingredients.
Both ingredients are part of Gnosis by Lesaffre portfolio:
Our comprehensive MenaQ7® portfolio and K2 Solutions Platform provide opportunities to incorporate the proven health benefits of Vitamin K2 into a broad range of finished products.
Our comprehensive MenaQ7® portfolio and K2 Solutions Platform provide opportunities to incorporate the proven health benefits of Vitamin K2 into a broad range of finished products.
Research highlights that Vitamin K2 as MK-7 is essential for supporting healthy aging across all life stages. Encouraging consumers to supplement with vitamin K2 is crucial for supporting both bone and heart health, and for this, you need formulation versatility.
A Versatile Vitamin K2 Portfolio
Since the introduction of MenaQ7® Vitamin K2, we have pioneered novel technologies to expand our product portfolio. Today, the MenaQ7® range meets the global demand for high-purity, stable, and well-researched Vitamin K2 as MK-7.
Our versatile Solutions Platform enables clinically proven benefits of MenaQ7® to be delivered in various forms, from traditional tablets and capsules to high-demand liquids and gummies. This also involves complex mineral combinations that require K2 protective like MenaQ7® Matrix, our clean-label, encapsulation-free technology.
The entire portfolio also meets consumer expectations of being naturally sourced, free from allergens and palm oils, vegan-friendly, and non-GMO. This makes MenaQ7® Vitamin K2 an ideal choice for health-conscious consumers seeking trustworthy, palatable, and proven supplements.
Curious to learn more? Download our brochure and discover how the MenaQ7® Portfolio can enhance your product offerings for various demographics.
>> DOWNLOAD NOW <<
Among the “ocean” of vitamins and supplements available, MenaQ7® Vitamin K2 is a standout choice. Why? Because MenaQ7® is the single most clinically proven Vitamin K2 on the market today.
Among the “ocean” of vitamins and supplements available, MenaQ7® Vitamin K2 is a standout choice. Why? Because MenaQ7® is the single most clinically proven Vitamin K2 on the market today.
MenaQ7® is the Vitamin K2 used in 22 human clinical trials, with more ongoing. This extensive research has substantiated our understanding of how Vitamin K2 benefits different populations, particularly for bone and heart health.
Vitamin K2’s Crucial Role in Bone & Heart Health
By activating Osteocalcin, MenaQ7® directs calcium to bones, improving bone mineral content and density in both children and adults. Further it activates Matrix Gla Protein, the strongest inhibitor of vascular calcification, and improves arterial elasticity, supporting a healthy cardiovascular system. These findings have been published in respected peer-reviewed publications.
Vitamin K2 Benefits Beyond Heart and Bone Health
MenaQ7® also offers additional health advantages by reducing oxidative stress in human muscle cells and inhibiting TNF, providing anti-inflammatory benefits. An exciting study are currently underway, evaluating MenaQ7® for its potential to decrease the frequency of migraine attacks.
Curious to learn more? Download our Vitamin K2 guideline, “Vitamin K2 for Brands That Aspire for More”, and discover why MenaQ7® Vitamin K2 is key to lifelong health.
> Get Your Science from the Source and Download our Brochure Today.
When you consider a vitamin essential through all stages of life, which one comes to mind? If Vitamin K2 isn’t on your radar yet, it should be. This nutrient plays a crucial role in maintaining overall health, especially for certain key demographics.
When you consider a vitamin essential through all stages of life, which one comes to mind? If Vitamin K2 isn’t on your radar yet, it should be. This nutrient plays a crucial role in maintaining overall health, especially for certain key demographics.
Let’s delve into why Vitamin K2 is vital for children, active lifestylers, those pursuing healthy aging, and menopausal women.
Vitamin K2 for Children
Childhood is a critical period for developing strong and dense bones. Ensuring adequate Vitamin K2 intake is essential for promoting bone development and overall health in children, primarily through its role in activating osteocalcin. Unfortunately, research shows that many children are deficient in this bone-building vitamin, putting them at risk of not achieving optimal bone strength. Daily supplementation with MenaQ7® Vitamin K2 has been clinically proven to effectively support children’s bone development.
Vitamin K2 Supporting an Active Lifestyle and Sport Performance
As active lifestylers, we prioritize holistic health, including the care of our bones, joints, and cardiovascular system. Peak bone mass typically reaches around age 30, making the maintenance of bone density a primary focus. Further, Vitamin K2 has been shown to increase ATP production and enhance cardiac output, significantly benefiting cardiovascular health.
Such benefits highlight the growing importance of Vitamin K2 for individuals aiming to enhance their sports performance during peak activity.
Vitamin K2 for Menopausal Women
A woman’s health undergoes significant changes throughout life, particularly during menopause due to hormone fluctuations. Cardiovascular issues become increasingly prevalent and are a major cause of death in women over the age of 65. Additionally, hormonal changes during menopause contribute to a decline in bone mass, increasing the risk of osteoporotic fractures.
Fortunately, daily supplementation with MenaQ7® Vitamin K2 offers a clinically proven, simple and cost-effective strategy to maintain both cardiovascular and bone health during this time of transformation.
Vitamin K2 for Healthy Aging
As the world’s population of people aged 60 is rapidly increasing, healthy aging is becoming a defining global trend. Quality of life is dependent on our physical ability and our mental acuity. Strategies to support this should be implemented sooner rather than later to ensure healthy aging.
Daily supplementation with MenaQ7® Vitamin K2 is clinically proven to inhibit age-related arterial stiffness and support bone health, both essential for preserving vitality and quality of life as we age.
Additionally, brain processing speed, which naturally slows with age, can be positively impacted by vitamin K2’s cardiovascular mechanism, supporting cognitive well-being.
By addressing the unique health needs of these demographics, MenaQ7® supports overall wellness and promotes a healthier, more active and fulfilling lifestyle.
> Download our MenaQ7® Brochure today!
Andrea Fuso, PhD, a 15-year research collaborator with focusing on cognitive health, has expanded his area of study to include Vitamin K2 in neurological support and has published highlighting K2’s role in neurological protection.
Recent research highlights the potential role of vitamin K2 in delaying cognitive decline. Our latest brochure explores how vitamin K2 can support brain health.
Maintaining a balance between physical and cognitive health is crucial for overall well-being. As we age, it’s essential to maintain not just our bodies but also our minds. The Natural Products industry is increasingly focusing on cognitive health, making this a perfect time to highlight the potential of vitamin K2 in supporting brain health.
The Relationship Between Vitamin K2 and Cognition
MenaQ7® research highlights vitamin K2’s ability to modulate oxidative stress, inflammation, and vascular stiffness, all conditions that can negatively impact our cognitive health. At the same time, MenaQ7® activates vitamin K-dependent proteins and supports mitochondrial function, positively affecting it. Simply put, Vitamin K2 ignites processes in the body that support a healthy brain.
Supporting Brain Health by Supporting Heart Health
MenaQ7® Vitamin K2 is clinically proven to enhance heart health by increasing arterial elasticity and reducing arterial stiffness. Studies show that arterial calcification and arterial stiffness increase the risk of dementia and cognitive impairment. This compelling connection places vitamin K2 at the center of the Heart-Brain Connection.
Vitamin K2 for A Sharper and Happier Mind
As we age, maintaining strong bones and a healthy cardiovascular system is critical, as is preserving cognitive acuity. MenaQ7® is the only clinically proven vitamin K2 as MK-7 supporting cardiovascular and bone health. An upcoming clinical study will test MenaQ7®’s effectiveness in reducing migraine attacks, a condition linked to arterial stiffness. The results could position vitamin K2 as a complete and all-round nutrient for healthy aging.
> Gain more in the brochure “VITAMIN K2 IN MOOD AND COGNITIVE”
LEGAL INFORMATION AND GENERAL CONDITIONS OF USE FOR THE www.menaq7.com WEBSITE Date of last update: May 7th, 2024 PUBLISHER Gnosis by Lesaffre, legal form, registered under N° LESAFFRE ET COMPAGNIE (LESAFFRE & CIE): RCS Paris B 316 055 672 with the capital of EUR [734,500.00] Trade and Companies Register, with its registered office at 41 … Continue reading Legal Notices
LEGAL INFORMATION AND GENERAL CONDITIONS OF USE FOR THE www.menaq7.com WEBSITE
Date of last update: May 7th, 2024
PUBLISHER
Gnosis by Lesaffre, legal form, registered under N° LESAFFRE ET COMPAGNIE (LESAFFRE & CIE): RCS Paris B 316 055 672 with the capital of EUR [734,500.00] Trade and Companies Register, with its registered office at 41 Rue Etienne Marcel – 75001 PARIS. “Lesaffre”
CONTACT
Administrative headquarters
137, Rue Gabriel Péri
F-59700 Marcq-en-Baroeul
Telephone: 00 33 +(0)3 20 81 61 00
GENERAL TERMS AND CONDITIONS OF USE
Lesaffre, publishes the website accessible at the URL address www.menaq7.com (hereinafter referred to as “the Site”) in order to provide general information on the activities of MenaQ7 from Gnosis by Lesaffre.
Within the meaning of these General Conditions of Use (hereinafter referred to as the “GCU”), the Lesaffre Group (hereinafter referred to as the “Lesaffre Group”) refers to the group made up of the company Lesaffre et Compagnie, a public limited company with a Board of Directors, registered under the SIRET number 31605567200018 in the Paris Trade and Companies Register, whose registered office is located at 41 rue Etienne Marcel, 75001 PARIS, as well as its subsidiaries, regardless of where they are established. In terms of shareholdings, control of companies and dominant influence, all companies meeting the criteria set out in Articles L233-1 to L233-3 and L233-16 of the French Commercial Code are defined under the terms of this article.
The purpose hereof is to define the terms and conditions under which any person, regardless of the access device (computer, tablet, etc.), the type of connection (private connection, public Wifi, etc.) and the place of connection, may access and use the Site (hereinafter referred to as the “Users” or individually as the “User”).
ARTICLE 1 – DESCRIPTION OF THE SITE
1.1 The website provides information on Gnosis by Lesaffre, its activities, its mission and its business, as well as news.
1.2 The Site allows the User to:
Access the websites of the Lesaffre Group’s other subsidiaries and operational units dedicated to the business unit Gnosis by Lesaffre;
- Contact Lesaffre using the contact forms
- Subscribe to email newsletter administrated by Gnosis by Lesaffre
- Accept or decline cookie usage for various operational and marketing activities
- Download research and materials created by Gnosis by Lesaffre
1.3 Lesaffre may develop the functionalities of the site, without this giving rise to any right to compensation whatsoever for the benefit of the user. Users are therefore expressly informed that the availability of all or part of the functionalities is at the discretion of Lesaffre International.
ARTICLE 2 – TECHNICAL CONDITIONS FOR ACCESSING AND USING THE SITE
2.1 The Site is compatible with standard browsers on the market. It is the User’s responsibility to check that they are using a browser version that is up to date at the time of consulting the Site. Failure to do so may result in difficulties accessing or using the Site.
2.2 Any hardware and/or software required to access and/or use the Site is the sole responsibility of the User, who is solely liable for the proper functioning of his/her equipment and Internet access. It is the User’s responsibility to ensure that he/she has an Internet connection enabling him/her to use the Site. It is also the User’s responsibility to take all appropriate measures to protect his/her own data, computer systems and/or software from contamination by any viruses.
2.3 The User undertakes to check that the configuration of his/her browser and operating system allows him/her to access and consult the Site. The User is responsible for resolving any bugs affecting his/her browser and/or operating system. The same applies to the detection and management of any virus likely to affect their terminal.
2.4 The Site is accessible unless interrupted for maintenance and/or in the event of force majeure and/or in the event of the occurrence of an event beyond the control of Lesaffre International. Lesaffre may not be held liable in the absence of fault, in the event of the unavailability of the site, for whatever reason, and will do its utmost to re-establish the service.
ARTICLE 3 – ACCEPTANCE AND AMENDMENT OF THE GCU
3.1 Access to and use of the Site are subject to compliance with these GCU. Therefore, before consulting the Site, all Users must read the GCU, which are accessible from the Site’s home page and from each of its pages.
3.2 The GCU may be modified by Lesaffre in order to take into account, in particular, changes to the functionalities of the Site, as well as applicable regulations. Any new version of the GCU will be made available to Users on the Site. Users should therefore consult the GCUs on a regular basis.
ARTICLE 4 – OBLIGATIONS – LIABILITY
4.1 The User undertakes to use the Site in accordance with these GCU. By accessing and using the Site, the User undertakes in particular not to:
-
- any use of the Site that contravenes applicable laws and regulations or violates the rights of third parties;
- any action which may cause prejudice to Lesaffre, to one or more entities of the Lesaffre Group or to another User;
- harm, hinder or distort the proper functioning of the Site;
- to probe, scan, scrape or technically analyze the Site;
- to test the vulnerability, performance or functionality of the Site for any reason other than those necessary for its use;
- circumvent the measures implemented by Lesaffre to guarantee the security of the site.
4.2 The user expressly acknowledges that if he/she does not respect these General Conditions of Use, Lesaffre or any of the subsidiaries of the Lesaffre Group may not be held liable. On the contrary, the user may be required to compensate Lesaffre and/or one or more of the subsidiaries of the Lesaffre Group for any costs, disbursements or prejudice in the event of all or part of them being called into question by another user and/or by a third party for an act attributable to the user.
4.3 The site is provided “as is”. Given this state of affairs, which is recognized and accepted by the user, Lesaffre International cannot be held responsible for the temporary or definitive impossibility of the user accessing the site or all or part of the site’s functionalities. Lesaffre International’s obligation to supply is limited to an obligation of means. Lesaffre International does not guarantee the durability or performance of the functionalities accessible on the website.
4.4 Neither Lesaffre nor the user may be held liable in the event of force majeure as defined by the laws of the country where is located Lesaffre’s headquarter and the corresponding jurisprudence.
4.5 Lesaffre cannot be held responsible for the consequences:
- the fault or negligence of the User;
- use of the Site by the User that does not comply with these GCU and/or applicable regulations;
- fraudulent use of the site by third parties, in violation of the security measures implemented by Lesaffre.
4.6 Lesaffre declines all responsibility for indirect damage which, consequently, does not give rise to any right to compensation.
ARTICLE 5 – INTELLECTUAL PROPERTY
5.1 The Site and each of its components, including but not limited to texts, images, illustrations, photographs, databases, media, software, graphics, logos, icons, sounds, company names, trademarks, product models, drawings, animated sequences with or without sound, and other documentation, and more generally, all visual or sound elements (hereinafter the “Intellectual Property Elements”) are protected by intellectual property rights.
5.2 Lesaffre holds the intellectual property rights to the intellectual property elements. Some of the intellectual property elements may also be the property of third parties or other subsidiaries of the Lesaffre Group who have granted a license to Lesaffre in order to incorporate them directly or indirectly into the Site.
5.3 As a result, the user is forbidden to reproduce or represent elements of intellectual property without the authorization of Lesaffre International, as such reproduction and/or representation may constitute an act of counterfeiting.
5.4 Any authorization for the reproduction and representation of intellectual property elements must be requested by post from the following address: Lesaffre – Service Communication – 101 rue de Menin 59700 Marcq-en Baroeul, France.
ARTICLE 6 – HYPERTEXT LINKS
6.1 The Site may contain hypertext links referring the User to websites published by other subsidiaries of the Lesaffre Group. Lesaffre International declines all responsibility for access to, use of and content on these websites.
6.2 To find out about the conditions of use of websites published by other subsidiaries of the Lesaffre Group or by sites published by third parties to the Lesaffre Group to which the Site may refer, the User is invited to consult the websites concerned, as well as the general conditions of use of said sites.
ARTICLE 7 – CONTACT
For any questions or complaints relating to the site and/or the application of these GCU, users may contact Lesaffre – Service Communication – 101 rue de Menin 59700 Marcq-en-Baroeul, France.
ARTICLE 8 – MISCELLANEOUS
8.1 In the event that one of the clauses of these GCU is declared null and void or inapplicable by the effect of a law, regulation or court decision rendered by a competent court having the force of res judicata, the other clauses will retain their validity and force.
8.2 The fact that Lesaffre does not take advantage of a breach by one (or more) user(s) of any of the stipulations of these General Conditions of Use may not be interpreted as a tolerance or waiver on its part to take advantage of such a breach in the future.
ARTICLE 9 – APPLICABLE LAW
9.1 These GCU are governed by the laws of the country where is located Lesaffre’s headquarter.
9.2 In the event of a dispute, the Parties will use their best endeavours to reach an amicable solution before referring the matter to the Courts. However, if the amicable stage fails, the most diligent party will refer the matter to the competent court in accordance with the applicable legal provisions.